53 related articles for article (PubMed ID: 22472546)
1. CYP3A variation, premenopausal estrone levels, and breast cancer risk.
Johnson N; Walker K; Gibson LJ; Orr N; Folkerd E; Haynes B; Palles C; Coupland B; Schoemaker M; Jones M; Broderick P; Sawyer E; Kerin M; Tomlinson IP; Zvelebil M; Chilcott-Burns S; Tomczyk K; Simpson G; Williamson J; Hillier SG; Ross G; Houlston RS; Swerdlow A; Ashworth A; Dowsett M; Peto J; Dos Santos Silva I; Fletcher O
J Natl Cancer Inst; 2012 May; 104(9):657-69. PubMed ID: 22472546
[TBL] [Abstract][Full Text] [Related]
2. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
Johnson N; Maguire S; Morra A; Kapoor PM; Tomczyk K; Jones ME; Schoemaker MJ; Gilham C; Bolla MK; Wang Q; Dennis J; Ahearn TU; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Aronson KJ; Augustinsson A; Baynes C; Freeman LEB; Beckmann MW; Benitez J; Bermisheva M; Blomqvist C; Boeckx B; Bogdanova NV; Bojesen SE; Brauch H; Brenner H; Burwinkel B; Campa D; Canzian F; Castelao JE; Chanock SJ; Chenevix-Trench G; Clarke CL; ; Conroy DM; Couch FJ; Cox A; Cross SS; Czene K; Dörk T; Eliassen AH; Engel C; Evans DG; Fasching PA; Figueroa J; Floris G; Flyger H; Gago-Dominguez M; Gapstur SM; García-Closas M; Gaudet MM; Giles GG; Goldberg MS; González-Neira A; ; Guénel P; Hahnen E; Haiman CA; Håkansson N; Hall P; Hamann U; Harrington PA; Hart SN; Hooning MJ; Hopper JL; Howell A; Hunter DJ; ; ; Jager A; Jakubowska A; John EM; Kaaks R; Keeman R; Khusnutdinova E; Kitahara CM; Kosma VM; Koutros S; Kraft P; Kristensen VN; Kurian AW; Lambrechts D; Le Marchand L; Linet M; Lubiński J; Mannermaa A; Manoukian S; Margolin S; Martens JWM; Mavroudis D; Mayes R; Meindl A; Milne RL; Neuhausen SL; Nevanlinna H; Newman WG; Nielsen SF; Nordestgaard BG; Obi N; Olshan AF; Olson JE; Olsson H; Orban E; Park-Simon TW; Peterlongo P; Plaseska-Karanfilska D; Pylkäs K; Rennert G; Rennert HS; Ruddy KJ; Saloustros E; Sandler DP; Sawyer EJ; Schmutzler RK; Scott C; Shu XO; Simard J; Smichkoska S; Sohn C; Southey MC; Spinelli JJ; Stone J; Tamimi RM; Taylor JA; Tollenaar RAEM; Tomlinson I; Troester MA; Truong T; Vachon CM; van Veen EM; Wang SS; Weinberg CR; Wendt C; Wildiers H; Winqvist R; Wolk A; Zheng W; Ziogas A; Dunning AM; Pharoah PDP; Easton DF; Howie AF; Peto J; Dos-Santos-Silva I; Swerdlow AJ; Chang-Claude J; Schmidt MK; Orr N; Fletcher O
Br J Cancer; 2021 Feb; 124(4):842-854. PubMed ID: 33495599
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.
Johnson N; Dudbridge F; Orr N; Gibson L; Jones ME; Schoemaker MJ; Folkerd EJ; Haynes BP; Hopper JL; Southey MC; Dite GS; Apicella C; Schmidt MK; Broeks A; Van't Veer LJ; Atsma F; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Ekici AB; Renner SP; Sawyer E; Tomlinson I; Kerin M; Miller N; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Guénel P; Truong T; Cordina E; Menegaux F; Bojesen SE; Nordestgaard BG; Flyger H; Milne R; Zamora MP; Arias Perez JI; Benitez J; Bernstein L; Anton-Culver H; Ziogas A; Clarke Dur C; Brenner H; Müller H; Arndt V; Dieffenbach AK; Meindl A; Heil J; Bartram CR; Schmutzler RK; Brauch H; Justenhoven C; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Dörk T; Bogdanova NV; Antonenkova NN; Lindblom A; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; Beesley J; ; ; Wu AH; Van den Berg D; Tseng CC; Lambrechts D; Smeets D; Neven P; Wildiers H; Chang-Claude J; Rudolph A; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Pensotti V; Couch FJ; Olson JE; Wang X; Fredericksen Z; Pankratz VS; Giles GG; Severi G; Baglietto L; Haiman C; Simard J; Goldberg MS; Labrèche F; Dumont M; Soucy P; Teo S; Yip CH; Phuah SY; Cornes BK; Kristensen VN; Grenaker Alnæs G; Børresen-Dale AL; Zheng W; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Devillee P; Figueroa J; Chanock SJ; Lissowska J; Sherman ME; Hall P; Schoof N; Hooning M; Hollestelle A; Oldenburg RA; Tilanus-Linthorst M; Liu J; Cox A; Brock IW; Reed MW; Cross SS; Blot W; Signorello LB; Pharoah PD; Dunning AM; Shah M; Kang D; Noh DY; Park SK; Choi JY; Hartman M; Miao H; Lim WY; Tang A; Hamann U; Försti A; Rüdiger T; Ulmer HU; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Slager S; Toland AE; Vachon C; Yannoukakos D; Shen CY; Yu JC; Huang CS; Hou MF; González-Neira A; Tessier DC; Vincent D; Bacot F; Luccarini C; Dennis J; Michailidou K; Bolla MK; Wang J; Easton DF; García-Closas M; Dowsett M; Ashworth A; Swerdlow AJ; Peto J; dos Santos Silva I; Fletcher O
Breast Cancer Res; 2014 May; 16(3):R51. PubMed ID: 24887515
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
Johnson N; De Ieso P; Migliorini G; Orr N; Broderick P; Catovsky D; Matakidou A; Eisen T; Goldsmith C; Dudbridge F; Peto J; Dos-Santos-Silva I; Ashworth A; Ross G; Houlston RS; Fletcher O
Cancer Res; 2016 Mar; 76(6):1485-1493. PubMed ID: 26964624
[TBL] [Abstract][Full Text] [Related]
5. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Maas P; Barrdahl M; Joshi AD; Auer PL; Gaudet MM; Milne RL; Schumacher FR; Anderson WF; Check D; Chattopadhyay S; Baglietto L; Berg CD; Chanock SJ; Cox DG; Figueroa JD; Gail MH; Graubard BI; Haiman CA; Hankinson SE; Hoover RN; Isaacs C; Kolonel LN; Le Marchand L; Lee IM; Lindström S; Overvad K; Romieu I; Sanchez MJ; Southey MC; Stram DO; Tumino R; VanderWeele TJ; Willett WC; Zhang S; Buring JE; Canzian F; Gapstur SM; Henderson BE; Hunter DJ; Giles GG; Prentice RL; Ziegler RG; Kraft P; Garcia-Closas M; Chatterjee N
JAMA Oncol; 2016 Oct; 2(10):1295-1302. PubMed ID: 27228256
[TBL] [Abstract][Full Text] [Related]
7. Mammographic breast density and breast cancer: evidence of a shared genetic basis.
Varghese JS; Thompson DJ; Michailidou K; Lindström S; Turnbull C; Brown J; Leyland J; Warren RM; Luben RN; Loos RJ; Wareham NJ; Rommens J; Paterson AD; Martin LJ; Vachon CM; Scott CG; Atkinson EJ; Couch FJ; Apicella C; Southey MC; Stone J; Li J; Eriksson L; Czene K; Boyd NF; Hall P; Hopper JL; Tamimi RM; ; Rahman N; Easton DF
Cancer Res; 2012 Mar; 72(6):1478-84. PubMed ID: 22266113
[TBL] [Abstract][Full Text] [Related]
8. A signature of balancing selection in the region upstream to the human UGT2B4 gene and implications for breast cancer risk.
Sun C; Huo D; Southard C; Nemesure B; Hennis A; Cristina Leske M; Wu SY; Witonsky DB; Olopade OI; Di Rienzo A
Hum Genet; 2011 Dec; 130(6):767-75. PubMed ID: 21660508
[TBL] [Abstract][Full Text] [Related]
9. Sex-Hormone-Binding Globulin Gene Polymorphisms and Breast Cancer Risk in Caucasian Women of Russia.
Ponomarenko I; Pasenov K; Churnosova M; Sorokina I; Aristova I; Churnosov V; Ponomarenko M; Reshetnikov E; Churnosov M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396861
[TBL] [Abstract][Full Text] [Related]
10. Do placental genes affect maternal breast cancer? Association between offspring's CGB5 and CSH1 gene variants and maternal breast cancer risk.
Chen Y; Kibriya MG; Jasmine F; Santella RM; Senie RT; Ahsan H
Cancer Res; 2008 Dec; 68(23):9729-34. PubMed ID: 19047151
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors.
Homer MV; Charo LM; Natarajan L; Haunschild C; Chung K; Mao JJ; DeMichele AM; Su HI
Menopause; 2017 Jun; 24(6):663-668. PubMed ID: 28118297
[TBL] [Abstract][Full Text] [Related]
12. CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients.
Attia HRM; Kamel MM; Ayoub DF; Abd El-Aziz SH; Abdel Wahed MM; El-Fattah SNA; Ablel-Monem MA; Rabah TM; Helal A; Ibrahim MH
Sci Rep; 2024 Apr; 14(1):7922. PubMed ID: 38575662
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.
Lau TY; Kwan HY
Mar Drugs; 2022 May; 20(6):. PubMed ID: 35736173
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.
Hjorth CF; Damkier P; Stage TB; Feddersen S; Hamilton-Dutoit S; Rørth M; Ejlertsen B; Lash TL; Ahern TP; Sørensen HT; Cronin-Fenton D
Breast Cancer Res Treat; 2022 Jul; 194(2):353-363. PubMed ID: 35501422
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450: Implications for human breast cancer.
Luo B; Yan D; Yan H; Yuan J
Oncol Lett; 2021 Jul; 22(1):548. PubMed ID: 34093769
[TBL] [Abstract][Full Text] [Related]
16. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Park J; Choi JY; Choi J; Chung S; Song N; Park SK; Han W; Noh DY; Ahn SH; Lee JW; Kim MK; Jee SH; Wen W; Bolla MK; Wang Q; Dennis J; Michailidou K; Shah M; Conroy DM; Harrington PA; Mayes R; Czene K; Hall P; Teras LR; Patel AV; Couch FJ; Olson JE; Sawyer EJ; Roylance R; Bojesen SE; Flyger H; Lambrechts D; Baten A; Matsuo K; Ito H; Guénel P; Truong T; Keeman R; Schmidt MK; Wu AH; Tseng CC; Cox A; Cross SS; kConFab Investigators ; Andrulis IL; Hopper JL; Southey MC; Wu PE; Shen CY; Fasching PA; Ekici AB; Muir K; Lophatananon A; Brenner H; Arndt V; Jones ME; Swerdlow AJ; Hoppe R; Ko YD; Hartman M; Li J; Mannermaa A; Hartikainen JM; Benitez J; González-Neira A; Haiman CA; Dörk T; Bogdanova NV; Teo SH; Mohd Taib NA; Fletcher O; Johnson N; Grip M; Winqvist R; Blomqvist C; Nevanlinna H; Lindblom A; Wendt C; Kristensen VN; Nbcs Collaborators ; Tollenaar RAEM; Heemskerk-Gerritsen BAM; Radice P; Bonanni B; Hamann U; Manoochehri M; Lacey JV; Martinez ME; Dunning AM; Pharoah PDP; Easton DF; Yoo KY; Kang D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069208
[TBL] [Abstract][Full Text] [Related]
17. Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.
Li H; Lampe JN
Arch Biochem Biophys; 2019 Sep; 673():108078. PubMed ID: 31445893
[TBL] [Abstract][Full Text] [Related]
18. The Influence of CYP3A4 Polymorphism in Sex Steroids as a Risk Factor for Breast Cancer.
Veiga MG; Felizi RT; Reis DG; Carelli Filho I; Fernandes CE; Souto RPD; Oliveira E
Rev Bras Ginecol Obstet; 2018 Nov; 40(11):699-704. PubMed ID: 30336495
[TBL] [Abstract][Full Text] [Related]
19. Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population.
Liu X; Huang X; Zhang S; Niu F; Ouyang Y; Shou Z; Liu J
Int J Clin Oncol; 2019 Feb; 24(2):179-188. PubMed ID: 30218411
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
